Results 1 to 10 of about 167,580 (260)

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions. [PDF]

Liver Int
Toyoda H, Hoshida Y, Parikh ND, Jalal PK, Piñero F, Mendizabal M, Ridruejo E, Cheinquer H, Casadei-Gardini A, Kanneganti M, Weinmann A, Peck-Radosavljevic M, Dufour JF, Radu P, Shiha G, Soliman R, Sarin SK, Kumar M, Wang JH, Tangkijvanich P, Sukeepaisarnjaroen W, Atsukawa M, Uojima H, Nozaki A, Nakamuta M, Takaguchi K, Hiraoka A, Abe H, Matsuura K, Watanabe T, Shimada N, Tsuji K, Ishikawa T, Mikami S, Itobayashi E, Johnson PJ, Singal AG.   +36 more
europepmc   +1 more source

Evaluation of metabolite biomarker candidates in detecting HCC in patients with liver cirrhosis. [PDF]

Metabolomics
Rashid MM, Varghese RS, Sajid MS, Sherif ZA, Kroemer A, Ressom HW.   +5 more
europepmc   +1 more source

Putative Imprinting Control Regions with Aberrant Blood-Based DNA Methylation are Associated with Hepatocellular Carcinoma Risk. [PDF]

J Hepatocell Carcinoma
DiFrank AJ, Corliss BA, Park JJH, Rogers M, Skaar DA, Jima DD, Cowley M, Murphy SK, Liu A, Moylan CA, Hoyo C.   +10 more
europepmc   +1 more source

Chronic adrenocortical activity and onset of Takotsubo syndrome. [PDF]

Eur J Cardiovasc Nurs
Salmoirago-Blotcher E, Keirns NG, Ouaddi S, Tripolone J, Liu C, Breault C, Dettmer A.   +6 more
europepmc   +1 more source

Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma

Disease Models & Mechanisms
Jagmohan Hooda, Jennifer M. Atkinson, Osama Shiraz Shah, Megan Yates, Daniel D. Brown, Morgan DeBerry, Stefano Cairo, Paolo Schiavini, Hsiu-Wen Tsai, Marianna Zipeto, Rohit Bhargava, Steffi Oesterreich, Adrian V. Lee   +12 more
doaj   +1 more source

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. [PDF]

Hepatol Commun
Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB.   +11 more
europepmc   +1 more source

Carob pod aqueous extract potentiates cisplatin efficacy and reduces toxicity in experimental hepatocellular carcinoma via mitochondrial and inflammatory pathway modulation. [PDF]

Bioresour Bioprocess
Darwish WS, El Sayed Khadr A, Abd El Naby Kamel M, Addissouky TA, Ghareeb AZ, Eldaim MAA, Razzaq MK, El Tantawy El Sayed I, Abdel-Bary HM, Ghareeb DA.   +9 more
europepmc   +1 more source

Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. [PDF]

Oncol Res
Yu G, Ge W, Yao H, Bai X, Wu J, Wang Y, Bai J, Cui Y, Han J.   +8 more
europepmc   +1 more source

Care-seeking among hepatocellular carcinoma patients in Uganda: health system navigation and its impact on diagnosis and survival in a prospective case-cohort study. [PDF]

BMJ Public Health
Nsibirwa SK, Aizire KJ, Okuku F, Ochola E, Mohareb AM, Ocama P, Kirk GD.   +6 more
europepmc   +1 more source

Hepatocellular Carcinoma-Related Mortality Trends Associated With Infective Versus Non-Infective Etiologies in ≥ 35 Years Age Group. [PDF]

Gastroenterology Res
Kakadiya J, Nasit Y, Vaghani M, Bhalala S, Fatima A, Rajapandian J, Varsadiya K, Ahmed Z.   +7 more
europepmc   +1 more source